Changes in ion fluxes represent one of the earliest events activated by
the interaction of insulin with its receptor. This proposal wants to
define the molecular mechanism by which the insulin receptor modifies ion
fluxes in target cells. It will be tested if the kinase activity of the
receptor is required for insulin stimulation of ion fluxes and if the
insulin receptor modifies the phosphorylation and/or subcellular
distribution of ion transporters. To test these hypotheses, this study
will define:
1. The effect of insulin on K fluxes and Na/K homeostasis in cells
expressing normal insulin receptors, focusing on insulin effect on the
Na,K-ATPase and the Na/K/Cl cotransporter.
2. Insulin stimulation of ion fluxes and Na/K homeostasis in cells with
activated or defective insulin receptor kinase to determine whether the
kinase activity of the receptor is required for the stimulation of ion
fluxes.
3. The molecular mechanism by which insulin activates ion transporters,
and specifically, whether insulin recruits preformed ion transporters on
the plasma membrane and/or affects their phosphorylation. This will be
determined by a combined approach involving measurement of insulin-induced
changes in ouabain binding and biotin labeling of ion transporters on the
plasma membrane of intact cells, Western blot analysis on subcellular
fractions (using antibodies specific for each transporter and anti-
phosphotyrosine antibodies), immunoprecipitation of 32P-transporters,
phosphoamino acid analysis and tryptic phosphopeptide mapping.
4. Insulin stimulation of the alpha1, alpha2, and beta1 isoforms of Na,K-
ATPase after their transfection into mammalian cells. The great abundance
of Na,K-pumps in transfected cells should facilitate the study of changes
of insulin-induced changes in their phosphorylation and subcellular
distribution.
Very little is currently known on the molecular mechanism(s) by which
insulin regulates ion fluxes. Ion transport across the plasma membrane by
the Na,K-ATPase is an energy-requiring process whose reduction has been
implicated in the pathogenesis of human obesity. In addition, changes in
insulin-stimulated ion fluxes contribute to acute and long-term
complications of diabetes. This study will define the molecular mechanism
by which insulin modifies ion fluxes and Na,K-ATPase activity and may
allow the design of better therapy to prevent obesity and acute or chronic
complications of diabetes.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
CHO cellsadipocytesbiological signal transductioncell typeimmunoprecipitationinsulininsulin receptorion transportmembrane potentialsmembrane transport proteinsmutantnorthern blottingsphosphorylationpotassiumprotein isoformsprotein tyrosine kinasereceptor bindingreceptor expressionrubidiumsite directed mutagenesissodiumsodium potassium exchanging ATPasetransfectionwestern blottings
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
DUNS Number
066469933
UEI
S352L5PJLMP8
Project Start Date
01-September-1995
Project End Date
31-August-2000
Budget Start Date
01-September-1995
Budget End Date
31-August-1996
Project Funding Information for 1995
Total Funding
$100,411
Direct Costs
$63,956
Indirect Costs
$36,455
Year
Funding IC
FY Total Cost by IC
1995
National Institute of Diabetes and Digestive and Kidney Diseases
$100,411
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R29DK048742-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R29DK048742-01A1
Patents
No Patents information available for 1R29DK048742-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R29DK048742-01A1
Clinical Studies
No Clinical Studies information available for 1R29DK048742-01A1
News and More
Related News Releases
No news release information available for 1R29DK048742-01A1
History
No Historical information available for 1R29DK048742-01A1
Similar Projects
No Similar Projects information available for 1R29DK048742-01A1